Optimizing effectiveness of CAR T cell therapy in lymphoma highlighted in special nordic issue

Chimeric antigen receptor (CAR) T cells, which can specifically recognize and target tumor cells, have resulted in complete responses in patients with leukemia, and although equally promising for… Source link